Ginkgo Bioworks Holdings Inc (NYSE: DNA) is -19.15% lower on its value in year-to-date trading and has touched a low of $5.00 and a high of $16.85 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The DNA stock was last observed hovering at around $10.79 in the last trading session, with the day’s loss setting it -0.81%.
Currently trading at $9.98, the stock is -0.95% and 16.59% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing -7.51% at the moment leaves the stock 12.21% off its SMA200. DNA registered 1.63% gain for a year compared to 6-month loss of -10.89%. The firm has a 50-day simple moving average (SMA 50) of $8.5598 and a 200-day simple moving average (SMA200) of $8.8939.
The stock witnessed a 17.41% gain in the last 1 month and extending the period to 3 months gives it a 47.20%, and is -21.54% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.24% over the week and 8.95% over the month.
Ginkgo Bioworks Holdings Inc (DNA) has around 834 employees, a market worth around $584.15M and $237.42M in sales. Profit margin for the company is -198.84%. Distance from 52-week low is 99.60% and -40.77% from its 52-week high. The company has generated returns on investments over the last 12 months (-43.63%).
The EPS is expected to grow by 41.87% this year.
Ginkgo Bioworks Holdings Inc (DNA) Top Institutional Holders
218.0 institutions hold shares in Ginkgo Bioworks Holdings Inc (DNA), with institutional investors hold 85.20% of the company’s shares. The shares outstanding are 43.08M, and float is at 38.16M with Short Float at 31.50%. Institutions hold 79.34% of the Float.
The top institutional shareholder in the company is VIKING GLOBAL INVESTORS LP with over 143.09 million shares valued at $47.83 million. The investor’s holdings represent 6.9686% of the DNA Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 138.96 million shares valued at $46.46 million to account for 6.7679 of the shares outstanding. The other top investors are BAILLIE GIFFORD & CO which holds 134.43 million shares representing 6.5469% and valued at over $44.94 million, while ANCHORAGE CAPITAL GROUP, L.L.C. holds 3.4021 of the shares totaling 69.85 million with a market value of $23.35 million.
